Clinical Trial Update: REMUNE + AMPLIVAX IR103 HIV/AIDS Phase III Safety & Efficacy Study [Phase 3]

View source ↗

Summary

This update describes a Phase III safety and efficacy trial of REMUNE in combination with Amplivax IR103 for HIV infection, sponsored by Immune Response BioPhar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• AMPLIVAX IR103
• Remune

Snippet

Sponsor: Immune Response BioPharma, Inc. | Conditions: HIV | Phase 3 | Status: UNKNOWN